Replies to post #105818 on Biotech Values

[mcbio]

Re: ANTH - Phase 2 ACS results

To assess whether ANTH is a good investment, I would want to know the outcome of the phase-2 ACS study described in clinicaltrials.gov/ct2/show/NCT00743925 .

The clinicaltrials.gov entry says this study finished in Apr 2010, but it does not contain the results.

Here are a few links from ANTH's Web site (initial and additional results):

http://investor.anthera.com/releasedetail.cfm?ReleaseID=423153

http://investor.anthera.com/releasedetail.cfm?ReleaseID=465785